Report
Global Healthcare Industry
This report reviews the global healthcare industry’s M&A and capital market landscape in 2021, a year shaped by both recovery efforts and ongoing pandemic-related challenges. Although nearly two years had passed since the onset of COVID-19, the pandemic continued to influence healthcare markets, investment decisions, and business strategies worldwide. Vaccine rollouts and government support measures varied significantly across regions, creating uneven recovery patterns and differing levels of market confidence. While large-scale vaccination campaigns in advanced economies improved sentiment and supported economic stability, the emergence of new COVID-19 variants highlighted the persistent uncertainty facing healthcare systems and businesses. Despite these challenges, the healthcare sector
